Partnering & Outsourcing Editorial

  1. Collaborating With Academia For Drug Discovery Targeting Immune-Mediated Diseases 9/16/2022

    Last year, Janssen Biotech and the University of Oxford established a collaboration to understand pathogenic pathways driving immune-mediated inflammatory diseases. They have been creating a cellular map of expressed genes and proteins. This article shares what the collaboration has accomplished so far.

  2. How To Become A Sponsor Of Choice For Your CRO Partners 7/26/2022

    Becoming a true sponsor of choice involves much more than simply saying the words. Drug discovery is a tough business and there are many parts that must seamlessly interact to get a product to regulatory approval.

  3. Novartis Lights A Beacon Of Hope For Diversity And Inclusion 7/21/2022

    In June 2022 Novartis announced the expansion of its Beacon of Hope program. The program is a 10-year, multimillion dollar program being conducted in collaboration with 26 historically Black colleges, universities, medical schools, Thurgood Marshall College Fund (TMCF) and other key partners.

  4. I Have Cancer, And I'm Thankful For The Life Science Industry 7/18/2022

    Your life can change in an instant. Mine changed in July 2021 when I was diagnosed with multiple myeloma. Here is why I am so thankful to pharma companies, patients, sites, and CROs.

  5. CVS Health Wants To Be Your New Clinical Research Site 7/6/2022

    CVS has been a well-regarded and recognized healthcare brand that started as a pharmacy but has since migrated into a recognized and trusted healthcare company. Now CVS is hoping to expand the relationship it has with patients by moving closer into primary care and clinical trials.

  6. CRO Oversight Essentials 6/30/2022

    Sponsors need to proactively identify and manage the risks involved with working with a CRO. This kind of oversight can help reduce the likelihood of negative consequences that could impact the quality of a trial.

  7. The Opportunities For Conducting Vaccine Clinical Research In Latin America 6/28/2022

    A few decades ago, the development of global clinical research that integrates low- and middle-income countries was considered a dream. Now it is a pressing need. This article discusses the history of vaccine research in Latin America, how the region could help solve the vaccine clinical trial diversity problem in the U.S., and why the region is a desirable destination for such clinical research. 

  8. What Should You Look For In A CRO Partner? 6/16/2022

    In May 2022, ISR Reports released the 14th edition of its Phase II/III CRO Benchmarking Report. The landscape for outsourcing clinical research changes every year, and the goal of the report is to help sponsor companies make educated decisions and to help CROs understand how they stack up against competitors when it comes to brand positioning and performance metrics.

  9. How To Build A Strong CRO Partnership And Find Drug Development Success 6/16/2022

    Building a collaborative and highly engaged partnership with a CRO to optimize study enrollment is critical for a company’s success, particularly with so much reliance on virtual interactions. Here are some tips on how to do just that.

  10. Clinical Trial Duration Trends & The Study Closeout Gap 6/14/2022

    Clinical study durations are increasing. Contributing significantly is what we will refer to as a study closeout gap. Is your company positioned to reverse this trend and reduce time to market for your new drugs and therapies? This article explores study duration data as well as related labor challenges and macroeconomic trends.